Intellipharmaceutics International Inc. | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(0%),Steven Boyd(0%)
Intellipharmaceutics International Inc. | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(9.99%),Steven Boyd(9.99%)
Intellipharmaceutics International Inc. | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(9.99%),Steven Boyd(9.99%)
Intellipharmaceutics International Inc. | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions
Intellipharmaceutics International Inc. | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
Intellipharmaceutics International Inc. | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
Intellipharmaceutics International Inc. | SC 13D/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities (Amendment)
Intellipharmaceutics International Inc. | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
Intellipharmaceutics International Inc. | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Anson Funds Management LP(0.5%),Anson Management GP LLC(0.5%), etc.
Intellipharmaceutics International Inc. | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Empery Asset Master, Ltd.(4.99%),Empery Tax Efficient II, LP(4.99%), etc.
Intellipharmaceutics International Inc. | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)
Intellipharmaceutics International Inc. | SC 13G: Statement of acquisition of beneficial ownership by individuals
Intellipharmaceutics International Inc. | SC 13G: Statement of acquisition of beneficial ownership by individuals-Empery Asset Master, Ltd.(9.99%),Empery Tax Efficient II, LP(9.99%), etc.
Intellipharmaceutics International Inc. | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Isa Odidi(12.7%),Amina Odidi(12.7%), etc.
Intellipharmaceutics International Inc. | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(9.99%),Armistice Capital Master Fund Ltd.(9.99%), etc.
Intellipharmaceutics International Inc. | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Isa Odidi(22.55%),Amina Odidi(22.55%), etc.
Intellipharmaceutics International Inc. | SC 13G: Statement of acquisition of beneficial ownership by individuals
Intellipharmaceutics International Inc. | D: Filing D
Intellipharmaceutics International Inc. | D: Filing D
Intellipharmaceutics International Inc. | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(18.9%),Armistice Capital Master Fund Ltd.(18.9%), etc.
No Data